Kyle R Jackson
Overview
Explore the profile of Kyle R Jackson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bisen S, Zeiser L, Getsin S, Chiang P, Stewart D, Herrick-Reynolds K, et al.
Am J Transplant
. 2023 Dec;
24(4):606-618.
PMID: 38142955
Kidney transplantation from blood type A2/A2B donors to type B recipients (A2→B) has increased dramatically under the current Kidney Allocation System (KAS). Among living donor transplant recipients, A2-incompatible transplants are...
2.
Long J, Motter J, Jackson K, Chen J, Orandi B, Montgomery R, et al.
Am J Transplant
. 2023 Sep;
23(12):1980-1989.
PMID: 37748554
Older compatible living donor kidney transplant (CLDKT) recipients have higher mortality and death-censored graft failure (DCGF) compared to younger recipients. These risks may be amplified in older incompatible living donor...
3.
Long J, Nijhar K, Jenkins R, Yassine A, Motter J, Jackson K, et al.
Liver Transpl
. 2023 Jan;
29(3):268-278.
PMID: 36651194
Steatotic livers represent a potentially underutilized resource to increase the donor graft pool; however, 1 barrier to the increased utilization of such grafts is the heterogeneity in the definition and...
4.
Bisen S, Getsin S, Chiang P, Herrick-Reynolds K, Zeiser L, Yu S, et al.
Transplant Direct
. 2022 Oct;
8(11):e1388.
PMID: 36284928
Methods: We used weighted Cox regression to compare mortality, death-censored graft failure, and all-cause graft loss in A2i versus ABO-compatible (ABOc) recipients. Results: Using Scientific Registry of Transplant Recipients data...
5.
Shafaat O, Liu Y, Jackson K, Motter J, Boyarsky B, Latif M, et al.
Radiology
. 2022 Oct;
306(3):e212403.
PMID: 36283115
Background Pre-liver transplant (LT) sarcopenia is associated with poor survival. Methods exist for measuring body composition with use of CT scans; however, it is unclear which components best predict post-LT...
6.
7.
Jackson K, Antunes D, Talukder A, Maleki A, Amagai K, Salmon A, et al.
PNAS Nexus
. 2022 Aug;
1(3):pgac124.
PMID: 36003074
Human leukocyte antigen class I (HLA-I) molecules bind and present peptides at the cell surface to facilitate the induction of appropriate CD8+ T cell-mediated immune responses to pathogen- and self-derived...
8.
Jackson K, Haugen C, Segev D
Transpl Int
. 2022 Jul;
35:10635.
PMID: 35845548
No abstract available.
9.
Sun Y, Li F, Sonnemann H, Jackson K, Talukder A, Katailiha A, et al.
Cells
. 2021 Sep;
10(9).
PMID: 34572028
Engineered T cell receptor T (TCR-T) cell therapy has facilitated the generation of increasingly reliable tumor antigen-specific adaptable cellular products for the treatment of human cancer. TCR-T cell therapies were...
10.
Haugen C, Bowring M, Jackson K, Garonzik-Wang J, Massie A, Chiang T, et al.
Liver Transpl
. 2021 Sep;
28(4):571-580.
PMID: 34559954
Despite a documented survival benefit, older liver donor (OLD, age ≥70) graft offers are frequently declined, with utilization worsening over the last decade. To understand how offer acceptance varies by...